Elanco Animal Health ELAN
NYSE ELAN
$26.41 -0.37 (-1.38%)
At close: Nov 16, 2026 · 4:00 PM EST

Elanco Animal Health (ELAN) Construction in Progress (2024)

Updated

Elanco Animal Health's Construction in Progress came in at $42 million for Q4 2024.

Analysis

Elanco Animal Health (ELAN) Construction in Progress (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn -
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -
10 Elanco Animal Health 13.25 Bn 11.29 Bn 720.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 42.00 Mn
API Access

Elanco Animal Health Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=ELAN&period=max&api_key=YOUR_API_KEY